You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RGEN Sale Disclosure
Loeillot Olivier · SEC Form 4 · Filed Sep 22, 2026
Sale
Calculated transaction value
$976.68K
Loeillot Olivier Chief Executive Officer
RGEN
Repligen Corp
RGEN
Transaction date
Sep 21, 2026
Public filing date
Sep 22, 2026
Filing lag
Filed 1 day later
RGEN daily price context
Close on/before transaction
$180.71
Sep 21, 2026
First close after public filing
$184.53
Sep 23, 2026
30-day return after filing
-3.15%
Through Oct 22, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 5,426 shares @ $180
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001628280-26-063026
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$1.75M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Repligen Corp RGEN | Exercise | Sep 21, 2026 | $769.35K |
| Repligen Corp RGEN Current | Sale | Sep 21, 2026 | $976.68K |
| Repligen Corp RGEN | Exercise | Sep 21, 2026 | $0 |